Detalhe da pesquisa
1.
Antithrombotic Therapy in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Undergoing Percutaneous Coronary Intervention: A North American Perspective: 2021 Update.
Circulation
; 143(6): 583-596, 2021 02 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33555916
2.
Acute Coronary Syndromes Among Patients with Prior Coronary Artery Bypass Surgery.
Curr Cardiol Rep
; 24(11): 1755-1763, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36094755
3.
Ticagrelor monotherapy in patients at high bleeding risk undergoing percutaneous coronary intervention: TWILIGHT-HBR.
Eur Heart J
; 42(45): 4624-4634, 2021 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34662382
4.
Ticagrelor monotherapy in patients with chronic kidney disease undergoing percutaneous coronary intervention: TWILIGHT-CKD.
Eur Heart J
; 42(45): 4683-4693, 2021 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34423374
5.
Finding sideline benefits-Of pandemics and same-day-discharge following rotational atherectomy.
Catheter Cardiovasc Interv
; 98(4): 689-690, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34596334
6.
Antithrombotic Therapy in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Undergoing Percutaneous Coronary Intervention: A North American Perspective-2018 Update.
Circulation
; 138(5): 527-536, 2018 07 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-30571525
7.
Drug-Coated Balloons for In-Stent Restenosis-Finally Leaving Nothing Behind for US Patients.
JAMA
; 331(12): 1011-1012, 2024 03 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-38460158
8.
Clinical features and outcomes of patients with type 2 myocardial infarction: Insights from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER) trial.
Am Heart J
; 196: 28-35, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29421012
9.
Discharge timing and outcomes after uncomplicated non-ST-segment elevation acute myocardial infarction.
Am Heart J
; 201: 103-110, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29910048
10.
Effects of genetic variation in protease activated receptor 4 after an acute coronary syndrome: Analysis from the TRACER trial.
Blood Cells Mol Dis
; 72: 37-43, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30055940
11.
The evolution of medical resident training and healthcare delivery: Good riddance to the "July effect".
Catheter Cardiovasc Interv
; 2023 Feb 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36748781
12.
Hybrid coronary revascularization: Time for a new comparator?
Catheter Cardiovasc Interv
; 91(2): 213-214, 2018 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29405596
13.
Trade-off of myocardial infarction vs. bleeding types on mortality after acute coronary syndrome: lessons from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER) randomized trial.
Eur Heart J
; 38(11): 804-810, 2017 Mar 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-28363222
14.
Evolving our learning and application of knowledge to practice-The ongoing challenges of time and cost in interventional cardiology.
Catheter Cardiovasc Interv
; 99(1): 17-18, 2022 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34994510
15.
Albuminuria and cardiovascular events in patients with acute coronary syndromes: Results from the TRACER trial.
Am Heart J
; 178: 1-8, 2016 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-27502846
16.
Effect of age on efficacy and safety of vorapaxar in patients with non-ST-segment elevation acute coronary syndrome: Insights from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER) trial.
Am Heart J
; 178: 176-84, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27502866
17.
Safety of an abbreviated duration of dual antiplatelet therapy (≤6 months) following second-generation drug-eluting stents for coronary artery disease: A systematic review and meta-analysis of randomized trials.
Catheter Cardiovasc Interv
; 87(4): 722-732, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26309050
18.
Arterial access site and outcomes in patients undergoing percutaneous coronary intervention with and without vorapaxar.
Catheter Cardiovasc Interv
; 88(2): 163-73, 2016 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-26698636
19.
Antiplatelet and anticoagulation therapy for acute coronary syndromes.
Circ Res
; 114(12): 1929-43, 2014 Jun 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-24902976
20.
Thrombin-receptor antagonist vorapaxar in acute coronary syndromes.
N Engl J Med
; 366(1): 20-33, 2012 Jan 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-22077816